Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

IQGAP1 Scaffold-MAP Kinase Interactions Enhance Multiple Myeloma Clonogenic Growth and Self-Renewal.

Gocke CB, McMillan R, Wang Q, Begum A, Penchev VR, Ali SA, Borrello I, Huff CA, Matsui W.

Mol Cancer Ther. 2016 Nov;15(11):2733-2739.

PMID:
27573425
2.

Identification of candidate genes for myeloma-induced osteocyte death based on microarray data.

Tian H.

J Orthop Surg Res. 2016 Jul 12;11(1):81. doi: 10.1186/s13018-016-0411-0.

3.

Sex-specific molecular genetic response to UVB exposure in Xiphophorus maculatus skin.

Boswell W, Boswell M, Titus J, Savage M, Lu Y, Shen J, Walter RB.

Comp Biochem Physiol C Toxicol Pharmacol. 2015 Dec;178:76-85. doi: 10.1016/j.cbpc.2015.07.007.

4.

Early Growth Response-1 Plays a Non-redundant Role in the Differentiation of B Cells into Plasma Cells.

Oh YK, Jang E, Paik DJ, Youn J.

Immune Netw. 2015 Jun;15(3):161-6. doi: 10.4110/in.2015.15.3.161.

5.

MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib.

Wirth M, Stojanovic N, Christian J, Paul MC, Stauber RH, Schmid RM, Häcker G, Krämer OH, Saur D, Schneider G.

Nucleic Acids Res. 2014;42(16):10433-47. doi: 10.1093/nar/gku763.

6.

Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.

Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D, Sougnez C, Knoechel B, Gould J, Saksena G, Cibulskis K, McKenna A, Chapman MA, Straussman R, Levy J, Perkins LM, Keats JJ, Schumacher SE, Rosenberg M; Multiple Myeloma Research Consortium., Getz G, Golub TR.

Cancer Cell. 2014 Jan 13;25(1):91-101. doi: 10.1016/j.ccr.2013.12.015.

7.

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.

Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I, Dawson KJ, Iorio F, Nik-Zainal S, Bignell GR, Hinton JW, Li Y, Tubio JM, McLaren S, O' Meara S, Butler AP, Teague JW, Mudie L, Anderson E, Rashid N, Tai YT, Shammas MA, Sperling AS, Fulciniti M, Richardson PG, Parmigiani G, Magrangeas F, Minvielle S, Moreau P, Attal M, Facon T, Futreal PA, Anderson KC, Campbell PJ, Munshi NC.

Nat Commun. 2014;5:2997. doi: 10.1038/ncomms3997.

8.

Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.

Abdi J, Chen G, Chang H.

Oncotarget. 2013 Dec;4(12):2186-207. Review. Erratum in: Oncotarget. 2015 Apr 10;6(10):7364. Oncotarget. 2015 Apr 10;6(10):7364.

9.

Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway.

Atsuta I, Liu S, Miura Y, Akiyama K, Chen C, An Y, Shi S, Chen FM.

Stem Cell Res Ther. 2013;4(5):111.

10.

Stimulation of Toll-like receptor-1/2 combined with Velcade increases cytotoxicity to human multiple myeloma cells.

Abdi J, Mutis T, Garssen J, Redegeld F.

Blood Cancer J. 2013 May 31;3:e119. doi: 10.1038/bcj.2013.17.

11.

Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma.

Kaiser MF, Johnson DC, Wu P, Walker BA, Brioli A, Mirabella F, Wardell CP, Melchor L, Davies FE, Morgan GJ.

Blood. 2013 Jul 11;122(2):219-26. doi: 10.1182/blood-2013-03-487884.

12.

Niche-modulated and niche-modulating genes in bone marrow cells.

Cohen Y, Garach-Jehoshua O, Bar-Chaim A, Kornberg A.

Blood Cancer J. 2012 Dec 14;2:e97. doi: 10.1038/bcj.2012.42.

13.

Phosphocaveolin-1 is a mechanotransducer that induces caveola biogenesis via Egr1 transcriptional regulation.

Joshi B, Bastiani M, Strugnell SS, Boscher C, Parton RG, Nabi IR.

J Cell Biol. 2012 Oct 29;199(3):425-35. doi: 10.1083/jcb.201207089. Erratum in: J Cell Biol. 2013 Mar 4;200(5):681.

14.

Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myeloma.

Saha MN, Jiang H, Yang Y, Zhu X, Wang X, Schimmer AD, Qiu L, Chang H.

PLoS One. 2012;7(1):e30215. doi: 10.1371/journal.pone.0030215.

15.

KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells.

Mannava S, Zhuang D, Nair JR, Bansal R, Wawrzyniak JA, Zucker SN, Fink EE, Moparthy KC, Hu Q, Liu S, Boise LH, Lee KP, Nikiforov MA.

Blood. 2012 Feb 9;119(6):1450-8. doi: 10.1182/blood-2011-04-346676.

Items per page

Supplemental Content

Support Center